Cancer patients will benefit substantially from the IRA's $2,000 cap on annual out-of-pocket medicine spending for Medicare Part D enrollees - a limit that's set to take effect in 2025.sukanyasitthikongsak / Moment / Getty Images Major pharmaceutical companies are profiting immensely from the second-leading cause of death in the United States by saddling cancer patients with tens of thousands of dollars in out-of-pocket costs, often forcing them to choose between treatment and other basic necessities.
[
add
]
[
|
|
...
]